Home AboutContactPersonal site

Prof. Amir Horev

Dermatology and Venereology Specialist and Pediatric Dermatologist

Alopecia areata (in Hebrew: oval baldness) is a relatively common disease that affects 0.1-0.2% of the population.

More than half of the cases first appear in childhood. Sometimes it involves members of the same family, but most often it appears without a family connection. Those affected by the disease will usually complain of one area and sometimes several areas on the scalp where hair loss and rapid baldness appear (sometimes within a few days). Usually, no inflammation or scaling is observed in the involved areas. Although the scalp is the most common area for baldness, sometimes the eyebrows, eyelashes, and even body hair are also involved.

Alopecia areata is considered an autoimmune phenomenon because the body's immune cells (T-lymphocyte cells) act against the hair follicles and cause hair loss due to the inflammation that occurs in the area. The causes of the disease are unknown, but hypotheses linking stress/mental stress as a cause have been raised in the medical literature. Sometimes patients who suffer from alopecia areata will suffer from other autoimmune symptoms/diseases, such as thyroid diseases, and therefore it is recommended to perform a blood test to rule out additional autoimmune diseases.

The course of the disease is not fixed, but about 90% of those suffering from the disease will enjoy hair regrowth within the first year, either spontaneously or with the help of medical treatments.

The smaller the area involved, the better the chance of a full recovery.

About a third of patients who have suffered from an episode of alopecia areata will suffer from a recurrence of the disease during their lifetime.

The most common treatments for alopecia areata are local application/injection of anti-inflammatory steroid preparations, but additional treatments exist and are determined according to the severity of the condition, response to previous treatments, and the wishes of the patient and his family. Recently, new treatments have been added to the health basket to treat severe cases of the disease, including drugs from the JAK inhibitor family.

Prof. Horev - Alopecia Areata - Doctors Website